Skip to content

NeoGenomics NEO Current Debt

Current Debt at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$900K-79.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$10M-98.0%
Natera, Inc. logo
Natera, Inc.NTRA
$80.31M0.0%
GeneDx Holdings logo
GeneDx HoldingsWGS
$0-100%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$424K
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.74B+158%
Enterprise value$2.05B+246%
P/S2.3×+1.3×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: NeoGenomics’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's current debt?
NeoGenomics (NEO) reported current debt of $1.7M in Q2 2026.
What is the long-term trend for NeoGenomics's current debt?
Over 5 years (2020 to 2025), NeoGenomics's current debt has grown at a -100.0% compound annual growth rate (CAGR), from $2.84M to $0.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.